Pain News and Research RSS Feed - Pain News and Research

Adding common epilepsy drug to morphine can result in better pain control, say IU researchers

Adding common epilepsy drug to morphine can result in better pain control, say IU researchers

Adding a common epilepsy drug to a morphine regimen can result in better pain control with fewer side effects. Moreover, the combination can reduce the dosage of the opioid needed to be effective, according to a team of pain researchers at Indiana University. [More]
Covered California unveils ad campaign, awards $14.6M for outreach

Covered California unveils ad campaign, awards $14.6M for outreach

And new enrollment numbers for that state show a growing individual insurance market, officials said. Meanwhile, a Nebraska woman recounts her experience as a navigator, and Oregon officials say a tax credit error will affect fewer people than expected. [More]
MOVANTIK tablets get FDA approval for treatment of OIC in patients with chronic, non-cancer pain

MOVANTIK tablets get FDA approval for treatment of OIC in patients with chronic, non-cancer pain

Nektar Therapeutics reported today that partner AstraZeneca today announced that the US Food and Drug Administration (FDA) approved MOVANTIK (naloxegol) tablets as the first once-daily oral peripherally-acting mu-opioid receptor antagonist (PAMORA) medication for the treatment of opioid-induced constipation (OIC), in adult patients with chronic, non-cancer pain. [More]
Viewpoints: New uninsured numbers are outdated; chiropractors' unusual move into nutrition

Viewpoints: New uninsured numbers are outdated; chiropractors' unusual move into nutrition

The federal government released some very reliable estimates of how many people had health insurance in the first three months of 2014. [More]
FDA grants Breakthrough Therapy designation to EYLEA Injection for treatment of diabetic retinopathy

FDA grants Breakthrough Therapy designation to EYLEA Injection for treatment of diabetic retinopathy

Regeneron Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted EYLEA (aflibercept) Injection Breakthrough Therapy designation for the treatment of diabetic retinopathy in patients with diabetic macular edema (DME). [More]
RT alone effective in decreasing dysphagia in patients with advanced esophageal cancer

RT alone effective in decreasing dysphagia in patients with advanced esophageal cancer

Radiation therapy (RT) alone is as effective in decreasing swallowing complications experienced by advanced esophageal cancer patients as RT combined with chemotherapy, thus allowing patients to forgo chemotherapy, according to research presented today at the American Society for Radiation Oncology's 56th Annual Meeting. [More]
Abbott announces initiation of ABSORB IV heart stent clinical trial

Abbott announces initiation of ABSORB IV heart stent clinical trial

Abbott announced today the start of the ABSORB IV clinical trial, which will test whether its Absorb Bioresorbable Vascular Scaffold (BVS) is more cost-effective and offers a higher quality of life than a best-in-class, permanent, metallic drug eluting stent. [More]
Bayer, Orion begin patient enrollment in ODM-201 Phase III trial for castration-resistant prostate cancer

Bayer, Orion begin patient enrollment in ODM-201 Phase III trial for castration-resistant prostate cancer

Bayer HealthCare and Orion Corporation, a pharmaceutical company based in Espoo, Finland, have begun to enroll patients in a Phase III trial with ODM-201, an investigational oral androgen receptor inhibitor in clinical development. [More]
WellStar establishes new health park in East Cobb

WellStar establishes new health park in East Cobb

WellStar East Cobb Health Park opened its doors September 15, serving as a comprehensive, one-stop shop for outpatient medical needs. [More]
Ramucirumab Phase III study meets primary endpoint in patients with metastatic colorectal cancer

Ramucirumab Phase III study meets primary endpoint in patients with metastatic colorectal cancer

Eli Lilly and Company today announced that the RAISE trial, a Phase III study of ramucirumab (CYRAMZA) in combination with chemotherapy in patients with metastatic colorectal cancer (mCRC), met its primary endpoint of overall survival. [More]
State highlights: States want home care worker wage changes delayed; Ga. delays nursing home rate hike

State highlights: States want home care worker wage changes delayed; Ga. delays nursing home rate hike

State officials that argued against providing overtime and minimum wage protections to the nation's 2 million home care workers are asking the Department of Labor to push back a Jan. 1 start date for the policy to take effect. State Medicaid officials concerned that their costs will rise are asking for a delay and tweaks to the policy, even though the Centers for Medicare and Medicaid Services finalized the rule a year ago. [More]
Loyola announces opening of new acupuncture clinic for patients with pelvic health disorders

Loyola announces opening of new acupuncture clinic for patients with pelvic health disorders

Loyola University Health System will open an acupuncture clinic for men and women with pelvic health disorders this fall. The clinic will use acupuncture to treat patients with common conditions such as pelvic pain, nausea from pelvic surgery, interstitial cystitis, painful bladder syndrome, postoperative pain, prostatitis and overactive bladder. [More]
AbbVie’s Phase 3 pivotal study shows HUMIRA is effective in reducing symptoms in HS

AbbVie’s Phase 3 pivotal study shows HUMIRA is effective in reducing symptoms in HS

AbbVie today announced results from a Phase 3 pivotal study demonstrating that HUMIRA® (adalimumab) is effective in reducing common clinical signs and symptoms in moderate-to-severe hidradenitis suppurativa (HS), specifically the number of abscesses and inflammatory nodules. [More]
DEA announces rules allowing participating pharmacies to collect medication for proper disposal

DEA announces rules allowing participating pharmacies to collect medication for proper disposal

It will soon be much easier for Americans to safely dispose of unwanted medications. The U.S. Department of Justice and the Drug Enforcement Administration (DEA) just announced rules allowing participating pharmacies, certain hospitals, clinics, and long-term care facilities to collect medication for proper disposal. The rules go into effect next month. [More]
Researchers show how activation of receptor provokes bone degradation of rheumatoid arthritis

Researchers show how activation of receptor provokes bone degradation of rheumatoid arthritis

Researchers at the University of Illinois at Chicago College of Medicine have shown for the first time how the activation of a receptor provokes the inflammation and bone degradation of rheumatoid arthritis -- and that activation of this one receptor, found on cells in the fluid of arthritic joints, is all that is required. [More]
Study provides new recommendations for men with lower back pain

Study provides new recommendations for men with lower back pain

A study using motion capture technology provides new information on the spinal strain produced by various sexual positions-suggesting that one position commonly recommended for all men with low back pain is not actually the best choice, reports a study in the journal Spine. [More]
Groundbreaking study reveals best positions to save spine during and after sex

Groundbreaking study reveals best positions to save spine during and after sex

Contrary to popular belief, spooning is not always the best sex position for those with a bad back, according to new research from the University of Waterloo. [More]
Study points to new therapeutic target to interrupt inflammation, bone erosion in rheumatoid arthritis

Study points to new therapeutic target to interrupt inflammation, bone erosion in rheumatoid arthritis

Researchers at the University of Illinois at Chicago College of Medicine have shown for the first time how the activation of a receptor provokes the inflammation and bone degradation of rheumatoid arthritis -- and that activation of this one receptor, found on cells in the fluid of arthritic joints, is all that is required. [More]
Latest health care products demonstrated at Novation's annual Innovative Technology Expo

Latest health care products demonstrated at Novation's annual Innovative Technology Expo

Novation, the leading health care services company, held its annual Innovative Technology Expo today in Irving, Texas. Medical suppliers, both large and small, are at the Expo to demonstrate the latest innovative health care products and meet with hospital clinicians and decision makers. [More]
Fogarty receives three grants for research focused on biodiversity conservation

Fogarty receives three grants for research focused on biodiversity conservation

In addition to diseases for which there are ineffective or no cures, key pathogens are becoming increasingly drug-resistant. [More]